AIM: Our aim was to investigate the relationships between the degree of IGF2 methylation and the metabolic status in obese children and adolescents. SUBJECTS AND METHODS: Eighty-five obese subjects aged 11.6 ± 2.1 years were studied. Anthropometry, metabolic parameters, blood pressure and body composition were assessed. DNA methylation analysis was performed by restriction enzyme digestion assay. The study population was subdivided into two groups according to the percentage of IGF2 cytidine-guanosine (CpG) island methylation. RESULTS: Twenty-two subjects showed intermediate methylation (a percentage of CpG site methylation comprised between 10 and 60%), 56 were hypomethylated (percentage of methylation lower than 10%), and only 1 showed a high rate of hypermethylation (percentage of methylation above 60%). Children with intermediate methylation showed significantly higher levels of triglycerides (107.6 ± 41.99 vs. 76.6 ± 30.18 mg/dl, p < 0.005) and a higher triglyceride/high-density lipoprotein-cholesterol ratio (2.23 ± 0.98 vs. 1.79 ± 0.98, p < 0.02) compared with hypomethylated children. CONCLUSIONS: These preliminary findings show for the first time a relationship between IGF2 methylation pattern and lipid profile in obese children. Although the correlation does not imply causation, if our findings are confirmed in further studies, IGF2 methylation might represent an epigenetic marker of metabolic risk.
AIM: Our aim was to investigate the relationships between the degree of IGF2 methylation and the metabolic status in obesechildren and adolescents. SUBJECTS AND METHODS: Eighty-five obese subjects aged 11.6 ± 2.1 years were studied. Anthropometry, metabolic parameters, blood pressure and body composition were assessed. DNA methylation analysis was performed by restriction enzyme digestion assay. The study population was subdivided into two groups according to the percentage of IGF2cytidine-guanosine (CpG) island methylation. RESULTS: Twenty-two subjects showed intermediate methylation (a percentage of CpG site methylation comprised between 10 and 60%), 56 were hypomethylated (percentage of methylation lower than 10%), and only 1 showed a high rate of hypermethylation (percentage of methylation above 60%). Children with intermediate methylation showed significantly higher levels of triglycerides (107.6 ± 41.99 vs. 76.6 ± 30.18 mg/dl, p < 0.005) and a higher triglyceride/high-density lipoprotein-cholesterol ratio (2.23 ± 0.98 vs. 1.79 ± 0.98, p < 0.02) compared with hypomethylated children. CONCLUSIONS: These preliminary findings show for the first time a relationship between IGF2 methylation pattern and lipid profile in obesechildren. Although the correlation does not imply causation, if our findings are confirmed in further studies, IGF2 methylation might represent an epigenetic marker of metabolic risk.
Authors: Yue Wu; Karen E Peterson; Brisa N Sánchez; Dana C Dolinoy; Adriana Mercado-Garcia; Martha M Téllez-Rojo; Jaclyn M Goodrich Journal: Epigenetics Date: 2018-12-22 Impact factor: 4.528
Authors: Pablo Gonzalez-Rodriguez; Jessica Cantu; Derek O'Neil; Maxim D Seferovic; Danielle M Goodspeed; Melissa A Suter; Kjersti M Aagaard Journal: Am J Obstet Gynecol Date: 2016-02-12 Impact factor: 8.661
Authors: Sonja M Kessler; Stephan Laggai; Elien Van Wonterg; Katja Gemperlein; Rolf Müller; Johannes Haybaeck; Roosmarijn E Vandenbroucke; Manfred Ogris; Claude Libert; Alexandra K Kiemer Journal: Front Physiol Date: 2016-04-25 Impact factor: 4.566
Authors: Anne Kammel; Sophie Saussenthaler; Markus Jähnert; Wenke Jonas; Laura Stirm; Andreas Hoeflich; Harald Staiger; Andreas Fritsche; Hans-Ulrich Häring; Hans-Georg Joost; Annette Schürmann; Robert W Schwenk Journal: Hum Mol Genet Date: 2016-04-28 Impact factor: 6.150
Authors: Philip James; Sara Sajjadi; Ashutosh Singh Tomar; Ayden Saffari; Caroline H D Fall; Andrew M Prentice; Smeeta Shrestha; Prachand Issarapu; Dilip Kumar Yadav; Lovejeet Kaur; Karen Lillycrop; Matt Silver; Giriraj R Chandak Journal: Int J Epidemiol Date: 2018-12-01 Impact factor: 7.196